Revenue | ₹416.15Cr |
Net Profits | ₹38.43Cr |
Net Profit Margins | 9.23% |
Astrazeneca Pharma India Ltd’s revenue jumped 23.9% since last year same period to ₹416.15Cr in the Q2 2024-2025. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated 5.12% jump in its revenue since last 3-months.
Astrazeneca Pharma India Ltd’s net profit fell -26.62% since last year same period to ₹38.43Cr in the Q2 2024-2025. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated 425.95% jump in its net profits since last 3-months.
Astrazeneca Pharma India Ltd’s net profit margin fell -40.77% since last year same period to 9.23% in the Q2 2024-2025. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated 410.07% jump in its net profit margins since last 3-months.
The revenue for Astrazeneca Pharma India Ltd in the Q2 results 2024 was ₹416.15Cr.
The net profit for Astrazeneca Pharma India Ltd in the Q2 results 2024 was ₹38.43Cr.
The net profit margin for Astrazeneca Pharma India Ltd in the Q2 results 2024 was 9.23%.
The revenue for Astrazeneca Pharma India Ltd in the Q2 results 2023 was ₹335.87Cr.
The net profit for Astrazeneca Pharma India Ltd in the Q2 results 2023 was ₹52.37Cr.
The net profit margin for Astrazeneca Pharma India Ltd in the Q2 results 2023 was 15.59%.